Extendicare (EXE) Competitors

dentalcorp (TSE:DNTL) and Extendicare (TSE:EXE) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, media sentiment, risk, earnings and community ranking.

Do insiders & institutionals have more ownership in DNTL or EXE?

50.3% of dentalcorp shares are held by institutional investors. Comparatively, 19.2% of Extendicare shares are held by institutional investors. 0.2% of dentalcorp shares are held by insiders. Comparatively, 13.9% of Extendicare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Which has more risk and volatility, DNTL or EXE?

dentalcorp has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500. Comparatively, Extendicare has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500.

Do analysts rate DNTL or EXE?

dentalcorp presently has a consensus target price of C$12.22, indicating a potential upside of 54.32%. Extendicare has a consensus target price of C$12.50, indicating a potential downside of 5.59%. Given dentalcorp's stronger consensus rating and higher possible upside, research analysts plainly believe dentalcorp is more favorable than Extendicare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
dentalcorp	0 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	3.00
Extendicare	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Does the media prefer DNTL or EXE?

In the previous week, Extendicare had 3 more articles in the media than dentalcorp. MarketBeat recorded 3 mentions for Extendicare and 0 mentions for dentalcorp. Extendicare's average media sentiment score of 0.67 beat dentalcorp's score of 0.00 indicating that Extendicare is being referred to more favorably in the news media.

Company	Overall Sentiment
dentalcorp	Neutral
Extendicare	Positive

Is DNTL or EXE more profitable?

Extendicare has a net margin of 4.48% compared to dentalcorp's net margin of -5.40%. Extendicare's return on equity of 64.13% beat dentalcorp's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
dentalcorp	-5.40%	-4.71%	0.77%
Extendicare	4.48%	64.13%	7.16%

Which has stronger earnings and valuation, DNTL or EXE?

Extendicare has lower revenue, but higher earnings than dentalcorp. dentalcorp is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
dentalcorp	C$1.49B	1.00	-C$80.68M	-C$0.43	-18.41
Extendicare	C$1.46B	0.76	C$65.46M	C$0.78	16.88

Does the MarketBeat Community favor DNTL or EXE?

Extendicare received 116 more outperform votes than dentalcorp when rated by MarketBeat users. However, 64.81% of users gave dentalcorp an outperform vote while only 47.34% of users gave Extendicare an outperform vote.

Company	Underperform	Outperform
dentalcorp	Outperform Votes 35 64.81%	Underperform Votes 19 35.19%
Extendicare	Outperform Votes 151 47.34%	Underperform Votes 168 52.66%

Summary

Extendicare beats dentalcorp on 10 of the 17 factors compared between the two stocks.